Physician profile
Jack Peterson
NPI 1508860487
$2,564.76
in general payments reported to CMS, 2019-2025
15 companies · $474 in 2025
The $474 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.87 · 2020: $53.32 · 2021: $494 · 2022: $188 · 2023: $745 · 2024: $530 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $422.08 | 2019-2025 | Dysport |
| Sientra, INC. | $394.90 | 2019-2022 | |
| Mentor Worldwide LLC | $314.67 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Mesh Suture INC | $194.01 | 2024 | |
| Integra Lifesciences Corporation | $166.45 | 2023 | Durasorb Monofilament Mesh |
| Davol INC. | $163.01 | 2023 | Phasix Mesh |
| Kowa Pharmaceuticals America, INC. | $152.64 | 2022-2023 | Seglentis |
| Acumed LLC | $146.83 | 2025 | Acumed, Inframe Implant, Innate Implant |
| Polynovo North America LLC | $137.47 | 2025 | Novosorb Btm |
| Musculoskeletal Transplant Foundation INC. | $134.10 | 2024 | |
| Innovation Technologies INC | $117.92 | 2023 | Irrisept |
| Motiva USA, LLC | $117.56 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $50.12 | 2024-2025 | |
| Organogenesis INC. | $30.00 | 2021 | |
| Ethicon US, LLC | $23.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.